This report analyzes the current and future use of electronic data capture (EDC) and electronic patient reported outcomes (ePRO) technologies in clinical trials. ISR quantifies study volume and vendor preference, identifies operational improvements, develops implications and recommendations for sponsors and service providers, and discusses the movement towards “eClinical” services. The report also provides extensive product profiles of 20 EDC and 14 ePRO products based on 710 unique end-user experiences.

1. EDC and ePRO Market
Trends and Service
Provider Performance
Info@ISRreports.com
©2013 Industry Standard Research www.ISRreports.com
PREVIEW

2. www.ISRreports.com ©2013 | Preview of: EDC and ePRO Market Trends and Service Provider Performance 2
act with confidence
Report Overview
101Site Coordinators /
Principal Investigators
155Pages
167Charts and Graphs
Q2,
2013
Publication Date
T
his report analyzes the current and future use of electronic data capture (EDC) and electronic
patient reported outcomes (ePRO) technologies in clinical trials. ISR quantifies study volume
and vendor preference, identifies operational improvements, develops implications and
recommendations for sponsors and service providers, and discusses the movement towards “eClinical”
services. The report also provides extensive product profiles of 20 EDC and 14 ePRO products based on
710 unique end-user experiences.
1. Executive Summary: In this section ISR summarizes the key findings and develops
implications and recommendations for sponsor and service provider organizations.
2. EDC Market Adoption: Presents the current state of the EDC market including the number
of systems sites use at one time, their preference for EDC vs. paper, and the current and
future EDC study penetration by development phase.
3. EDC Operational Improvements: Outlines suggested improvements for EDC software and
examines the most important EDC attributes that can help improve study operations.
4. EDC Service Provider Performance: Provides sponsors and service providers a look into
the most preferred EDC vendors and profiles how sites rate each of the 20 leading EDC
service providers on six key performance attributes.
5. ePRO Market Adoption: Presents the current state of the ePRO market including the
number of systems sites use at one time, their preference for ePRO vs. paper diaries, and
the current and future ePRO study penetration by development phase.
6. ePRO Operational Improvements: Outlines suggested improvements for ePRO software
and examines the most important ePRO attributes that can help improve study operations.
7. ePRO Service Provider Performance: Provides sponsors and service providers a look into
the most preferred ePRO vendors and profiles how sites rate each of the 14 leading ePRO
service providers on nine key performance attributes.
8. eClinical Environment: Discusses site familiarity and desire for using direct data capture
technologies, their use of eClinical solutions from the leading CROs, and identifies the best
CROs for eClinical support.
• Project Managers
• Outsourcing
• Clinical Operations
• Data Management
• CROs
• Technology Service Providers
Major Sections:
Regions Analyzed: Valuable for:
64% North America
28% Europe
8% Asia-Latin America-Middle East/ India

3. www.ISRreports.com ©2013 | Preview of: EDC and ePRO Market Trends and Service Provider Performance 3
act with confidence
Report Overview
What you will learn in this report:
For Sponsors and CROs:
• 710 Site-coordinators and Principal
Investigators’ product experiences and
preferences across 20 EDC and 14 ePRO
platforms
• Past and future penetration of EDC
and ePRO technologies (by Phase of
development)
• Which technology providers have the
best integration capabilities with other
technologies
For Technology Providers:
• Detailed performance profiles, product
satisfaction, and end-user preference for
34 major technology providers across core
performance attributes
• Current and future adoption estimates for
EDC and ePRO technologies
How you can use this report:
For Sponsors and CROs:
• Select or uncover a new technology partner
that enhances your relationships with sites
by understanding the needs, wants, and
preferences of clinical sites
• Learn how investigative sites would
recommend improving the trial process
• Benchmark your organization’s use of EDC
and ePRO against broad industry averages
For Technology Provides:
• Benchmark your performance against your
competition
• Anticipate how changes in trial volume and
adoption/penetration will affect your future
business opportunities
• Identify operational improvements and
product characteristics that impact trial
success and optimize user experience
• Acceliant/ Trianz
• Bioclinica/ Phoenix Data Systems
• Clinical Ink
• Clinipace (Tempo)
• Cmed (Timaeus)
• DataLabs/ Perceptive Informatics
• DATATRAK
• DSG
• Medidata (Rave)
• MedNet Solutions
• Medrio
• Merge
• Nextrials (Prism)
• Octagon (Fuse)
• OmniComm (TrialMaster)
• OpenClinica
• Oracle/ Phase Forward (InForm)
• Registrat-MAPI
• Target Health
• Xclinical (Marvin)
• Almac
• Biomedical Systems
(Michelangelo)
• Bracket Global/ Arrowhead
• Clinipace (Tempo)
• CRF Health
• DSG (eDiaryLink)
• ERT/ invivodata
• Exco Intouch
• ICOPhone (ICON)
• Outcome
• Perceptive Informatics
• PHT
• Registrat-MAPI
• Symfo
ePRO Products Included:
EDC Products Included:

4. www.ISRreports.com ©2013 | Preview of: EDC and ePRO Market Trends and Service Provider Performance 4
act with confidence
Table of Contents
Full table of contents and additional sample pages available in the full preview,
free on our website:
http://www.isrreports.com/industry-reports/edc-and-epro-market-trends-
and-service-provider-performance

5. www.ISRreports.com ©2013 | Preview of: EDC and ePRO Market Trends and Service Provider Performance 5
act with confidence
Table of Contents
Familiarity level of leading ePRO providers
Use/ experience level of leading ePRO providers
Most preferred ePRO software application
Rationale for why an ePRO system is preferred
ePRO vendor satisfaction
Human-machine interface (how intuitive the SW is to
operate) for the ePRO device
Human-machine interface (how intuitive the SW is to
operate) for the ePRO web reporting tool
Patient/ subject satisfaction with the ePRO application
Durability of the products once the subject has the
device
Logistic of getting the devices to your site
Logistic of returning the devices to the vendor
Technical support from the vendor
Integration capabilities with other applications (EDC,
IVR)
Overall satisfaction with the ePRO product
Almac profile
Biomedical Systems (Michelangelo) profile
Bracket Global/ Arrowhead profile
Clinipace (Tempo) profile
CRF Health profile
DSG (eDiaryLink) profile
ERT/ invivodata profile
Exco Intouch profile
ICOPhone (ICON) profile
Outcome profile
Perceptive Informatics profile
PHT profile
Registrat-MAPI profile
Symfo profile
eClinical Environment
Familiarity with EDC as source data – FDA guidance
Interest in direct data capture devices
Experience with integrated eClinical systems
eClinical systems used
eClinical benefits to sites
Most beneficial eClinical features to improve site
operations
Most used CROs in past 18 months
Most recommended CROs for eClinical technology
Best CRO for eClinical support
Respondent Demographics
Practice setting
Job role
Clinical trial responsibility
Clinical trial recent activity
Geography
Familiarity with EDC and ePRO
Personal number of clinical trials, past 12 months
Site number of clinical trials, past 12 months
Industry/ clinical trial experience
Therapeutic area responsibility
About Industry Standard Research

6. www.ISRreports.com ©2013 | Preview of: EDC and ePRO Market Trends and Service Provider Performance 6
act with confidence
www.isrreports.com
©2013|
EDC-­‐ePRO
Market
Trends
and
Service
Provider
Performance
25
Summary: percent of trials using EDC by development phase
“Thinking back over the past two years, what percent of clinical trials conducted at
your site used EDC as the data collection tool (vs. paper CRFs)? Your best estimate is
fine.”
(Base = 100)
“Thinking ahead over the next two years, what percent of clinical trials conducted at
your site do you believe will use EDC as the data collection tool (vs. paper CRFs)? Your
best estimate is fine.”
(Base = 100)
66%
74%
68%
36%
79%
84%
75%
60%
0%
20%
40%
60%
80%
100%
Phase
IV
Phase
III
Phase
II
Phase
I
Next
two
years
Past
two
years
© 2013 Industry Standard Research
Sample Page
Data available in full report
© 2013 Industry Standard Research
Summary: Percent of trials using EDC by development Phase

7. www.ISRreports.com ©2013 | Preview of: EDC and ePRO Market Trends and Service Provider Performance 7
act with confidence
Sample Page
Full table of contents and additional sample pages available in the full preview,
free on our website:
http://www.isrreports.com/industry-reports/edc-and-epro-market-trends-
and-service-provider-performance

8. www.ISRreports.com ©2013 | Preview of: EDC and ePRO Market Trends and Service Provider Performance 8
act with confidence
Ordering Information
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma
and pharma services industries. With over a decade of experience in the industry, ISR delivers an un-
matched level of domain expertise.
For more information about our off-the-shelf intelligence and custom research offerings, please visit
our Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.
About Industry Standard Research
Pricing for this report is available in the full preview, free on our website:
http://www.isrreports.com/industry-reports/edc-and-epro-market-trends-
and-service-provider-performance